Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
40
CPHI Quote, Financials, Valuation and Earnings
Last price:
$1.65
Seasonality move
:
13.36%
Day range:
$1.63 - $1.73
52-week range:
$1.20 - $3.35
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.45x
P/B ratio:
0.69x
Volume:
2.6K
Avg. volume:
10.6K
1-year change:
-14.87%
Market cap:
$5.9M
Revenue:
$4.5M
EPS (TTM):
-$1.03
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
CPHI
China Pharma Holdings, Inc.
|
-- | -- | -- | -- | -- |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$3M | -$0.88 | 14.03% | -95.43% | $0.85 |
|
NNVC
NanoViricides, Inc.
|
-- | -$0.20 | -- | -26.67% | $7.00 |
|
OGEN
Oragenics, Inc.
|
-- | -- | -- | -- | $2.00 |
|
PTN
Palatin Technologies
|
-- | -$0.17 | -- | -67.93% | -- |
|
TOVX
Theriva Biologics, Inc.
|
-- | -$0.38 | -- | -94.42% | $7.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
CPHI
China Pharma Holdings, Inc.
|
$1.80 | -- | $5.9M | -- | $0.00 | 0% | 1.45x |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$1.06 | $0.85 | $133.6M | 1.78x | $0.80 | 0% | 2.06x |
|
NNVC
NanoViricides, Inc.
|
$1.11 | $7.00 | $20M | -- | $0.00 | 0% | -- |
|
OGEN
Oragenics, Inc.
|
$0.86 | $2.00 | $711.4K | -- | $0.00 | 0% | 0.53x |
|
PTN
Palatin Technologies
|
$0.09 | -- | $2.4M | -- | $0.00 | 0% | -- |
|
TOVX
Theriva Biologics, Inc.
|
$0.20 | $7.00 | $6.8M | -- | $0.00 | 0% | 0.33x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
CPHI
China Pharma Holdings, Inc.
|
29.58% | -1.772 | 56.09% | 0.09x |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
37.25% | 2.113 | 8.08% | 1.85x |
|
NNVC
NanoViricides, Inc.
|
-- | 0.464 | -- | 0.95x |
|
OGEN
Oragenics, Inc.
|
3.86% | -0.075 | 36.62% | 3.97x |
|
PTN
Palatin Technologies
|
-- | 1.358 | -- | -- |
|
TOVX
Theriva Biologics, Inc.
|
29.07% | -3.365 | 66.16% | 0.68x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
CPHI
China Pharma Holdings, Inc.
|
-$257.6K | -$628.1K | -29.08% | -43.41% | -83.07% | -$277.6K |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$42K | -$1.2M | -208.55% | -306.03% | -224.38% | -$1.8M |
|
NNVC
NanoViricides, Inc.
|
-$132.8K | -$1.8M | -92.29% | -92.29% | -- | -$1.7M |
|
OGEN
Oragenics, Inc.
|
-- | -$3.1M | -311.49% | -509.23% | -- | -$3M |
|
PTN
Palatin Technologies
|
-- | -- | -- | -- | -- | -- |
|
TOVX
Theriva Biologics, Inc.
|
-$28K | -$4.4M | -148.18% | -171.04% | -- | -$4.3M |
China Pharma Holdings, Inc. vs. Competitors
-
Which has Higher Returns CPHI or NBY?
NovaBay Pharmaceuticals, Inc. has a net margin of -86.16% compared to China Pharma Holdings, Inc.'s net margin of -255.85%. China Pharma Holdings, Inc.'s return on equity of -43.41% beat NovaBay Pharmaceuticals, Inc.'s return on equity of -306.03%.
Company Gross Margin Earnings Per Share Invested Capital CPHIChina Pharma Holdings, Inc.-34.07% -$0.17 $12.1M NBYNovaBay Pharmaceuticals, Inc.8.06% -$0.22 $2.6M -
What do Analysts Say About CPHI or NBY?
China Pharma Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand NovaBay Pharmaceuticals, Inc. has an analysts' consensus of $0.85 which suggests that it could fall by -19.81%. Given that NovaBay Pharmaceuticals, Inc. has higher upside potential than China Pharma Holdings, Inc., analysts believe NovaBay Pharmaceuticals, Inc. is more attractive than China Pharma Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CPHIChina Pharma Holdings, Inc.0 0 0 NBYNovaBay Pharmaceuticals, Inc.1 0 0 -
Is CPHI or NBY More Risky?
China Pharma Holdings, Inc. has a beta of 1.028, which suggesting that the stock is 2.826% more volatile than S&P 500. In comparison NovaBay Pharmaceuticals, Inc. has a beta of 0.569, suggesting its less volatile than the S&P 500 by 43.103%.
-
Which is a Better Dividend Stock CPHI or NBY?
China Pharma Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NovaBay Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.80 per share. China Pharma Holdings, Inc. pays -- of its earnings as a dividend. NovaBay Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CPHI or NBY?
China Pharma Holdings, Inc. quarterly revenues are $756.2K, which are larger than NovaBay Pharmaceuticals, Inc. quarterly revenues of $521K. China Pharma Holdings, Inc.'s net income of -$651.5K is higher than NovaBay Pharmaceuticals, Inc.'s net income of -$1.3M. Notably, China Pharma Holdings, Inc.'s price-to-earnings ratio is -- while NovaBay Pharmaceuticals, Inc.'s PE ratio is 1.78x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for China Pharma Holdings, Inc. is 1.45x versus 2.06x for NovaBay Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CPHIChina Pharma Holdings, Inc.1.45x -- $756.2K -$651.5K NBYNovaBay Pharmaceuticals, Inc.2.06x 1.78x $521K -$1.3M
-
Which has Higher Returns CPHI or NNVC?
NanoViricides, Inc. has a net margin of -86.16% compared to China Pharma Holdings, Inc.'s net margin of --. China Pharma Holdings, Inc.'s return on equity of -43.41% beat NanoViricides, Inc.'s return on equity of -92.29%.
Company Gross Margin Earnings Per Share Invested Capital CPHIChina Pharma Holdings, Inc.-34.07% -$0.17 $12.1M NNVCNanoViricides, Inc.-- -$0.10 $7.2M -
What do Analysts Say About CPHI or NNVC?
China Pharma Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand NanoViricides, Inc. has an analysts' consensus of $7.00 which suggests that it could grow by 530.63%. Given that NanoViricides, Inc. has higher upside potential than China Pharma Holdings, Inc., analysts believe NanoViricides, Inc. is more attractive than China Pharma Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CPHIChina Pharma Holdings, Inc.0 0 0 NNVCNanoViricides, Inc.0 0 0 -
Is CPHI or NNVC More Risky?
China Pharma Holdings, Inc. has a beta of 1.028, which suggesting that the stock is 2.826% more volatile than S&P 500. In comparison NanoViricides, Inc. has a beta of 1.158, suggesting its more volatile than the S&P 500 by 15.816%.
-
Which is a Better Dividend Stock CPHI or NNVC?
China Pharma Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NanoViricides, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. China Pharma Holdings, Inc. pays -- of its earnings as a dividend. NanoViricides, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CPHI or NNVC?
China Pharma Holdings, Inc. quarterly revenues are $756.2K, which are larger than NanoViricides, Inc. quarterly revenues of --. China Pharma Holdings, Inc.'s net income of -$651.5K is higher than NanoViricides, Inc.'s net income of -$1.8M. Notably, China Pharma Holdings, Inc.'s price-to-earnings ratio is -- while NanoViricides, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for China Pharma Holdings, Inc. is 1.45x versus -- for NanoViricides, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CPHIChina Pharma Holdings, Inc.1.45x -- $756.2K -$651.5K NNVCNanoViricides, Inc.-- -- -- -$1.8M
-
Which has Higher Returns CPHI or OGEN?
Oragenics, Inc. has a net margin of -86.16% compared to China Pharma Holdings, Inc.'s net margin of --. China Pharma Holdings, Inc.'s return on equity of -43.41% beat Oragenics, Inc.'s return on equity of -509.23%.
Company Gross Margin Earnings Per Share Invested Capital CPHIChina Pharma Holdings, Inc.-34.07% -$0.17 $12.1M OGENOragenics, Inc.-- -$1.96 $10.2M -
What do Analysts Say About CPHI or OGEN?
China Pharma Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Oragenics, Inc. has an analysts' consensus of $2.00 which suggests that it could grow by 131.36%. Given that Oragenics, Inc. has higher upside potential than China Pharma Holdings, Inc., analysts believe Oragenics, Inc. is more attractive than China Pharma Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CPHIChina Pharma Holdings, Inc.0 0 0 OGENOragenics, Inc.1 0 0 -
Is CPHI or OGEN More Risky?
China Pharma Holdings, Inc. has a beta of 1.028, which suggesting that the stock is 2.826% more volatile than S&P 500. In comparison Oragenics, Inc. has a beta of 0.922, suggesting its less volatile than the S&P 500 by 7.781%.
-
Which is a Better Dividend Stock CPHI or OGEN?
China Pharma Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Oragenics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. China Pharma Holdings, Inc. pays -- of its earnings as a dividend. Oragenics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CPHI or OGEN?
China Pharma Holdings, Inc. quarterly revenues are $756.2K, which are larger than Oragenics, Inc. quarterly revenues of --. China Pharma Holdings, Inc.'s net income of -$651.5K is higher than Oragenics, Inc.'s net income of -$3.1M. Notably, China Pharma Holdings, Inc.'s price-to-earnings ratio is -- while Oragenics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for China Pharma Holdings, Inc. is 1.45x versus 0.53x for Oragenics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CPHIChina Pharma Holdings, Inc.1.45x -- $756.2K -$651.5K OGENOragenics, Inc.0.53x -- -- -$3.1M
-
Which has Higher Returns CPHI or PTN?
Palatin Technologies has a net margin of -86.16% compared to China Pharma Holdings, Inc.'s net margin of --. China Pharma Holdings, Inc.'s return on equity of -43.41% beat Palatin Technologies's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CPHIChina Pharma Holdings, Inc.-34.07% -$0.17 $12.1M PTNPalatin Technologies-- -- -- -
What do Analysts Say About CPHI or PTN?
China Pharma Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Palatin Technologies has an analysts' consensus of -- which suggests that it could grow by 7338.9%. Given that Palatin Technologies has higher upside potential than China Pharma Holdings, Inc., analysts believe Palatin Technologies is more attractive than China Pharma Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CPHIChina Pharma Holdings, Inc.0 0 0 PTNPalatin Technologies0 0 0 -
Is CPHI or PTN More Risky?
China Pharma Holdings, Inc. has a beta of 1.028, which suggesting that the stock is 2.826% more volatile than S&P 500. In comparison Palatin Technologies has a beta of 0.939, suggesting its less volatile than the S&P 500 by 6.103%.
-
Which is a Better Dividend Stock CPHI or PTN?
China Pharma Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Palatin Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. China Pharma Holdings, Inc. pays -- of its earnings as a dividend. Palatin Technologies pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CPHI or PTN?
China Pharma Holdings, Inc. quarterly revenues are $756.2K, which are larger than Palatin Technologies quarterly revenues of --. China Pharma Holdings, Inc.'s net income of -$651.5K is higher than Palatin Technologies's net income of --. Notably, China Pharma Holdings, Inc.'s price-to-earnings ratio is -- while Palatin Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for China Pharma Holdings, Inc. is 1.45x versus -- for Palatin Technologies. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CPHIChina Pharma Holdings, Inc.1.45x -- $756.2K -$651.5K PTNPalatin Technologies-- -- -- --
-
Which has Higher Returns CPHI or TOVX?
Theriva Biologics, Inc. has a net margin of -86.16% compared to China Pharma Holdings, Inc.'s net margin of --. China Pharma Holdings, Inc.'s return on equity of -43.41% beat Theriva Biologics, Inc.'s return on equity of -171.04%.
Company Gross Margin Earnings Per Share Invested Capital CPHIChina Pharma Holdings, Inc.-34.07% -$0.17 $12.1M TOVXTheriva Biologics, Inc.-- -$0.45 $9.5M -
What do Analysts Say About CPHI or TOVX?
China Pharma Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Theriva Biologics, Inc. has an analysts' consensus of $7.00 which suggests that it could grow by 3398.25%. Given that Theriva Biologics, Inc. has higher upside potential than China Pharma Holdings, Inc., analysts believe Theriva Biologics, Inc. is more attractive than China Pharma Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CPHIChina Pharma Holdings, Inc.0 0 0 TOVXTheriva Biologics, Inc.1 1 0 -
Is CPHI or TOVX More Risky?
China Pharma Holdings, Inc. has a beta of 1.028, which suggesting that the stock is 2.826% more volatile than S&P 500. In comparison Theriva Biologics, Inc. has a beta of 0.342, suggesting its less volatile than the S&P 500 by 65.818%.
-
Which is a Better Dividend Stock CPHI or TOVX?
China Pharma Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Theriva Biologics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. China Pharma Holdings, Inc. pays -- of its earnings as a dividend. Theriva Biologics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CPHI or TOVX?
China Pharma Holdings, Inc. quarterly revenues are $756.2K, which are larger than Theriva Biologics, Inc. quarterly revenues of --. China Pharma Holdings, Inc.'s net income of -$651.5K is higher than Theriva Biologics, Inc.'s net income of -$4.4M. Notably, China Pharma Holdings, Inc.'s price-to-earnings ratio is -- while Theriva Biologics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for China Pharma Holdings, Inc. is 1.45x versus 0.33x for Theriva Biologics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CPHIChina Pharma Holdings, Inc.1.45x -- $756.2K -$651.5K TOVXTheriva Biologics, Inc.0.33x -- -- -$4.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
69
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 4
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
41
SMX alert for Dec 4
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
43
HY alert for Dec 4
Hyster-Yale, Inc. [HY] is up 1.92% over the past day.
